Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA

Watchlist Manager
Kiniksa Pharmaceuticals Ltd Logo
Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
Watchlist
Price: 22.15 USD -2.08% Market Closed
Market Cap: 1.6B USD
Have any thoughts about
Kiniksa Pharmaceuticals Ltd?
Write Note

Kiniksa Pharmaceuticals Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Kiniksa Pharmaceuticals Ltd
Operating Income Peer Comparison

Comparables:

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
Operating Income
-$26.2m
CAGR 3-Years
47%
CAGR 5-Years
32%
CAGR 10-Years
N/A

See Also

What is Kiniksa Pharmaceuticals Ltd's Operating Income?
Operating Income
-26.2m USD

Based on the financial report for Sep 30, 2024, Kiniksa Pharmaceuticals Ltd's Operating Income amounts to -26.2m USD.

What is Kiniksa Pharmaceuticals Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
32%

Over the last year, the Operating Income growth was -36%. The average annual Operating Income growth rates for Kiniksa Pharmaceuticals Ltd have been 47% over the past three years , 32% over the past five years .

Back to Top